Welcome to our dedicated page for Enstar Group SEC filings (Ticker: ESGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to untangle the actuarial tables hidden in Enstar Group’s run-off disclosures? Because Enstar Group Limited’s filings weave together Bermuda, U.S., and U.K. regulations, even seasoned analysts can miss pivotal reserve movements or capital-release transactions buried in footnotes.
Stock Titan solves that problem. Our AI reads every Enstar Group annual report 10-K simplified and each Enstar Group quarterly earnings report 10-Q filing within minutes, surfacing answers to questions investors actually ask, like “Is loss-reserve redundancy growing?� or “Which segment drove this quarter’s investment income?� Interactive dashboards translate actuarial jargon into clear metrics, while real-time alerts flag Enstar Group 8-K material events explained so you never miss a fresh acquisition or reserve adjustment.
Need to monitor management’s confidence? Get instant notifications for Enstar Group insider trading Form 4 transactions. Our platform links every Enstar Group Form 4 insider transactions real-time filing to accompanying 8-K announcements, letting you spot patterns in executive behaviour. The same engine demystifies the Enstar Group proxy statement executive compensation, showing how incentive structures align with run-off performance.
- AI-powered summaries of 10-K, 10-Q, 8-K, and Form 4 filings
- Segment-level runoff reserve trends and investment portfolio shifts
- Comparative tools for year-over-year earnings report filing analysis
- Downloadable highlights for auditors, analysts, and risk managers
Whether you’re understanding Enstar Group SEC documents with AI for the first time or fine-tuning a valuation model, Stock Titan gives you complete, current, and comprehensible data—no more hunting through hundreds of pages.
Enstar Group Limited (ESGR) � Schedule 13D/A Amendment No. 1 discloses the closing of the $338-per-share cash acquisition of Enstar by investment vehicles advised by Sixth Street Partners on 2 July 2025. The filing is made by Elk Evergreen Investments, Elk Cypress Investments, TSSP Sub-Fund HoldCo, and Alan Waxman (collectively, the “Reporting Persons�).
Key points:
- Merger consummated: Ordinary Shares were converted to $338 in cash, excluding rollover shares and certain award-related shares. Enstar becomes a wholly-owned subsidiary of a Bermuda holding structure (Parent, TopCo, Deer entities).
- Ownership eliminated: Each Reporting Person now holds 0 shares; aggregate beneficial ownership falls to 0 %, triggering the amendment and termination of 13D reporting obligations.
- Additional rollover investors: Three individuals (David Ni, Nazar Alobaidat, Audrey Taranto) agreed to contribute a de-minimis <1 % indirect interest in the post-merger Parent through new support agreements.
- Delisting & deregistration: Enstar requested NASDAQ to suspend trading, file Form 25 for ordinary and preferred depositary shares, and intends to file Form 15 to terminate Exchange Act reporting within 90 days.
- No further transactions: Aside from the merger, the Reporting Persons executed no ESGR trades in the past 60 days.
The amendment is largely administrative—formalising zero ownership, documenting closing mechanics, and outlining the path to Enstar’s transition to a private entity with no public reporting duties.
GBank Financial Holdings Inc. (GBFH) has released its 2025 Definitive Proxy Statement in advance of the virtual Annual Meeting scheduled for 2:00 p.m. PT on Friday, 1 August 2025. Only holders of the 14,042,011 outstanding shares of common stock as of the 13 June 2025 record date are entitled to vote.
Key voting items
- Proposal 1 � Election of three Class III directors (Kathryn S. Lever, Todd A. Nigro, Alan C. Sklar) to serve until the 2028 AGM. Directors are elected by plurality; cumulative voting is not permitted.
- Proposal 2 � Ratification of RSM US LLP as independent registered public accounting firm for fiscal year ending 31 Dec 2025. Requires majority of votes cast.
The Board unanimously recommends shareholders vote FOR all proposals. Proxies are solicited by the Board and may be voted via mail, internet, telephone, or at the meeting platform (Zoom ID 856 1782 9948; password 066066).
Corporate governance highlights
- Board size fixed at ten; currently 60 % (6/10) independent under Nasdaq rules.
- Separate Chair (Edward M. Nigro) and CEO (T. Ryan Sullivan) roles; majority-independent Audit, Compensation, and Nominating & Governance Committees.
- Audit Committee chaired by Kathryn S. Lever; Lever and Charles W. Griege, Jr. are designated “audit committee financial experts.�
- Average 2024 Board attendance exceeded 75 % except for Ms. Lever.
- Virtual-only meeting structure is allowed under Nevada law, expected to reduce cost and expand access.
Executive compensation (FY 2024)
- Executive Chairman Edward M. Nigro: total comp $829k (base $250k; bonus $194k; stock $366k; other $20k).
- CEO T. Ryan Sullivan: total comp $1.0 m (base $400k; bonus $194k; stock $366k; other $43k).
- EVP & Chief SBA Officer Nancy M. DeCou: total comp $4.37 m, driven by $4.00 m in SBA-related commissions.
The company qualifies as an “emerging growth company� and therefore provides scaled disclosure; no Say-on-Pay vote is required this year.
Notable operational context from biographies
- GBFH shares began trading on Nasdaq in 2025; the bank has appeared on OTCQX “Best 50� for three consecutive years and S&P’s Top-100 community bank list (2016-2022).
- The bank continues to expand its Gaming FinTech initiatives, including launch of a Visa credit card tailored to the gaming sector (2022).
Shareholders can access full proxy materials, the 2024 Annual Report and voting instructions at www.gbankfinancialholdings.com/annual-meeting.
SEC Form 4 filing: Director Jessica M. Bibliowicz reported the grant of 1,446 restricted stock units (RSUs) of Apollo Global Management, Inc. (APO) on 01 July 2025 under the company’s 2019 Omnibus Equity Incentive Plan. Each RSU converts into one share of common stock when vested and, per Bibliowicz’s deferral election, shares will be issued after she leaves the Board.
Following the grant, the director’s total beneficial ownership rises to 14,472 shares, including 6,802 previously issued RSUs. The transaction carried a stated price of $0 because it is an equity award, not an open-market purchase.
- The RSUs vest in installments, subject to continued service.
- No derivative securities were bought or sold, and no cash changed hands.
- The filing does not disclose any sales, dispositions, or purchases by the insider beyond the single RSU grant.
The activity is routine board compensation and does not materially alter the company’s share count or governance profile, but it affirms alignment of director incentives with shareholder value.
On 2 July 2025, Enstar Group Limited (symbol: ESGR) and its financing subsidiary filed Post-Effective Amendment No. 1 to six previously effective Form S-3 shelf registration statements. The amendment follows the completion of a series of mergers, effective the same day, in which Enstar became a wholly owned subsidiary of Elk Bidco Limited. Because public offerings under these shelves have been terminated, the registrants are deregistering all securities that remained unsold under the following registration numbers: 333-270204, 333-220889, 333-215144, 333-195562, 333-151461 and 333-143064. No new securities are being offered, and no financial results are provided. Signatures were executed by Audrey B. Taranto (General Counsel) for Enstar Group Limited and Jennifer Miu (Chief Financial Officer) for Enstar Finance LLC.
Enstar Group Limited (ESGR) and subsidiary Enstar Finance LLC filed a Post-Effective Amendment No. 1 on Form S-3 with the SEC on 2 July 2025. The filing follows the closing of a series of mergers effected pursuant to the 29 July 2024 Agreement and Plan of Merger under which Enstar survived as a wholly owned subsidiary of Elk Bidco Limited (“Parent�).
Because the company has terminated all public offerings in connection with the mergers, the amendment deregisters all unsold securities remaining under six previously effective shelf registration statements (Nos. 333-270204, 333-220889, 333-215144, 333-195562, 333-151461 and 333-143064). These shelves had covered ordinary shares, preference shares, depositary shares, various classes of debt, warrants, purchase contracts and units, some offered by Enstar and some by selling shareholders.
The document is administrative in nature—no new securities are being offered, no capital is being raised and no financial results are disclosed. Signatures were provided by General Counsel Audrey B. Taranto on behalf of Enstar Group Limited and CFO Jennifer Miu on behalf of Enstar Finance LLC.
Form 4 filing for Apollo Global Management, Inc. (APO): Director Mitra O’Neill (professionally known as Mitra Hormozi) reported the grant of 1,446 restricted stock units (RSUs) on 07/01/2025 under the company’s 2019 Omnibus Equity Incentive Plan. Each RSU converts into one share of APO common stock upon vesting, with settlement deferred until the director leaves the board. Following the award, the director’s direct holdings total 30,344 shares (including 7,049 RSUs already held). In addition, 2,500 shares are indirectly held through an entity controlled by the director’s spouse. No shares were sold, no cash changed hands, and no derivative securities were involved. This filing reflects routine, service-based equity compensation aimed at aligning director interests with shareholders rather than signaling a change in company fundamentals.
Form 4 overview � Hillenbrand, Inc. (HI), filed 07/02/2025
Senior Vice President J. Michael Whitted reported multiple equity transactions dated 06/30/2025:
- Restricted-stock unit (RSU) exercise (Code M): 17,989 common shares converted at a $0 exercise price.
- Tax-withholding disposition (Code F): 5,272 shares surrendered at a weighted-average $20.60 (price range $20.27�$20.60).
Resulting direct ownership moved from an implied 68,756 shares pre-exercise to 81,473 shares ±è´Ç²õ³Ù-·É¾±³Ù³ó³ó´Ç±ô»å¾±²Ô²µâ€”a +12,717-share net increase (â‰�+18.5%).
Derivative holdings were also updated. Whitted received or recorded awards under six RSU programs, adding 1, -17,989, 19, 52, 90 and 84 units, leaving:
- 53,954 RSUs from the 6/28/2024 award
- 35,965 RSUs from the same grant after the M conversion
- 1,726; 4,709; 8,153; and 7,630 RSUs under earlier & matching programs
All RSUs carry dividend-equivalent rights and vest in annual tranches through March 31 2028.
Interpretation for investors: No open-market sale occurred aside from statutory tax withholding; the executive’s net equity exposure to HI increased materially. Such exercises are routine around vesting dates but can be viewed as a mild vote of confidence when accompanied by net share accumulation. The transaction size (�$1.6 M based on market price) is not large versus Hillenbrand’s ~$3.5 B market cap and is unlikely to move the stock, yet it modestly strengthens insider-ownership alignment.
Form 4 overview: Director John Paulson reported a routine equity grant from Bausch Health Companies Inc. (NYSE: BHC) dated 06/30/2025.
- Transaction: 9,384 restricted share units (RSUs) issued in lieu of quarterly cash board fees; coded “A� (acquired) at a cost basis of $0.
- Direct holdings: Increase to 341,439 common shares after the grant.
- Indirect holdings: Paulson-managed funds continue to own 32,791,702 shares; Paulson disclaims beneficial ownership beyond his pecuniary interest.
- Nature of grant: RSUs convert 1-for-1 into common shares at vesting, further aligning the director’s incentives with shareholders but creating negligible dilution given BHC’s ~365 million shares outstanding.
No cash was exchanged and there were no derivative transactions. The filing reflects standard board compensation rather than an active investment decision, so immediate market impact is expected to be minimal.
Form 4 filing overview: Clover Health Investments (CLOV) reported insider activity by Jamie L. Reynoso, listed as “CEO, Medicare Advantage.� On 30 June 2025 Ms. Reynoso earned 217,523 Class A shares through the final tranche of a March 16 2023 performance-based RSU award. To satisfy withholding taxes, the company automatically sold 85,596 shares at $2.79 per share. After the automatic sale, Ms. Reynoso’s direct ownership stands at 3,328,328 Class A shares, up roughly 132 k shares versus the prior balance.
- Nature of transaction: “A� code denotes acquisition from equity award; “F� code denotes shares withheld for taxes—neither represents an open-market trade.
- Cost basis: RSUs were settled at no cash cost to the insider; only the tax-withholding sale carries a market price.
- Alignment impact: The executive retains a sizable equity stake (�3.3 million shares), reinforcing incentive alignment, but no new cash investment was made.
Overall, the filing reflects routine equity-compensation vesting and related tax withholding rather than a discretionary buy or sell decision. Market impact is expected to be neutral barring other catalysts.
Form 4 filing overview: Clover Health Investments (CLOV) reported insider activity by Jamie L. Reynoso, listed as “CEO, Medicare Advantage.� On 30 June 2025 Ms. Reynoso earned 217,523 Class A shares through the final tranche of a March 16 2023 performance-based RSU award. To satisfy withholding taxes, the company automatically sold 85,596 shares at $2.79 per share. After the automatic sale, Ms. Reynoso’s direct ownership stands at 3,328,328 Class A shares, up roughly 132 k shares versus the prior balance.
- Nature of transaction: “A� code denotes acquisition from equity award; “F� code denotes shares withheld for taxes—neither represents an open-market trade.
- Cost basis: RSUs were settled at no cash cost to the insider; only the tax-withholding sale carries a market price.
- Alignment impact: The executive retains a sizable equity stake (�3.3 million shares), reinforcing incentive alignment, but no new cash investment was made.
Overall, the filing reflects routine equity-compensation vesting and related tax withholding rather than a discretionary buy or sell decision. Market impact is expected to be neutral barring other catalysts.